Cristina Sánchez (Madrid, Spain, 1971) graduated in
Biology at Madrid Complutense University in 1994. She started her scientific
career as an undergraduate student at the laboratory of Dr. Ramos and Dr.
Fernández-Ruiz (School of Medicine, Complutense University), where she first
took contact with the field of cannabinoid research. Once graduated, she moved
to Dr. Guzmán’s laboratory (School of Biology, Complutense University), where
she studied the effect of cannabinoids on lipid and carbohydrate intermediate
metabolism first and on cancer cell proliferation later. She obtained her PhD
with Honors in Biochemistry and Molecular Biology at Complutense University in
2000. During her postdoc at Dr. Piomelli’s laboratory (University of California
Irvine, 2000-2003) she studied the involvement of another group of bioactive
lipids (lysophosphatidic acid and related compounds) on pain initiation.
In 2004, Cristina returned to Spain
with a “Ramón y Cajal” contract (aimed at repatriating Spanish
researchers from abroad) and she started coordinating a new line
of research within Dr. Guzmán’s laboratory. In particular, the
goal of her research is to understand and exploit cannabinoids
as potential antitumoral agents in breast cancer. More recently,
she has also focused her attention on new cannabinoid receptors
and their possible involvement in cannabinoid antitumoral action
in breast cancer and other type of tumors.